Extrapulmonary Tuberculosis Despite Preventive Therapy During Adalimumab for Psoriasis
Clicks: 20
ID: 322434
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
5.7
/100
20 views
10 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #12 of 188 articles by views in clinical and experimental dermatology
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 188 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
This report details three cases of active extrapulmonary tuberculosis (TB) arising in patients with psoriasis and documented latent tuberculosis infection. Notably, these patients developed active disease despite having initiated or completed appropriate TB preventive treatment, while receiving adalimumab monotherapy.
| Reference Key |
openalex_W7170183244
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Tiago Torres, Martim Luz |
| Journal | clinical and experimental dermatology |
| Year | 2026 |
| DOI |
10.1093/ced/llag323
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.